Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

✍ Scribed by N. Freemantle; S. Satram-Hoang; E.-T. Tang; P. Kaur; D. Macarios; S. Siddhanti; J. Borenstein; D. L. Kendler; on behalf of the DAPS Investigators

• Publisher: Springer-Verlag
• Year: 2011
• Tongue: English
• Weight: 349 KB
• Volume: 23
• Category: Article
• ISSN: 0937-941X
• DOI: 10.1007/s00198-011-1780-1